Member Info for Pickuzawinnah

I'm kind-of with you, smiller. Kind of. This issue of focus v diversified operations is all about managing risk. I'd like to see a clear 3-point priority/resources plan with (say) Hancook at 50%, EH at 30%, and San Celso at 20%. Greenland and Donovan can pause until income begins from one (or all!) of those three.

Try reading the RNSs and researching the company website/Twitter. It's all in there.

Sorry but I doubt anyone's going to put on a plate for you a prediction of what's going to happen. But many here are invested because we expect very good things over the medium term.

Indeed he is, napth. And I welcome it.
I'm very enthusiastic about UFO, and pretty much convinced it's going for 3-5 bag territory in the next twelve months. There may even be a speculator spike on top. But HH's voice is a moderator to that belief. It's good to have someone challenge beliefs otherwise we risk echo-chamber delusion.

Anyway, good to see the SP settle at placing. Money in the bank and immediate projects for it to create value (exactly what BBG promises).

Completely agree with your sentiments dickie.
Placings are necessary until revenue streams begin. This one feels like it's to enable that to happen through Hancook, and to firm up EH, and start the exploration around SanCelso (etc) which may not reach fruition until 2024, by which time UFO will be surfing a big wave of iron ore, that will hopefully have been extended by the planned further exploration/drilling in its Pilbara tenements.
To anyone that's a novice and feeling a little hurt today, let me offer an experience from last year. I bought a few shares in VAL. Checking back, I see it was at 6.9p in late April. A couple of days later it was up at 12p. WIN !
Then there's a placing and back down to 7p. Gah !
It trundled along for about three months in a channel and then flew. It seriously flew. It 8-bagged (briefly).
EQT did something similar. Bought in at .48p then there's a placing followed by litigation. Yikes !
Three months later it's up at 6-bag territory.

Next couple of months here are loaded with a couple of potentially significant steps forward. having my stop-loss triggered this morning, I bought straight back in for a reason.

Are we seeing a trawl for stop-losses ? Bit of a tree shake prior to Nov/Dec activity ?
Top up indeed !

Don't.
Change the locks.

I had a "safety net" stop loss triggered. But it's given me an opportunity to buy in again at a lower value.
Thought there's be a placing but expected it after EH announcement. Gah !
Still, 2022 is looking tremendous here. Glad to be back in. :)

Classic undermining post from someone with very few posts.
Read the full statement. Unrecognised revenue, meaning the invoice has been paid, and will be recognised in the year ahead. Still, commercially, a big step forward.

Potential acquisition is an interesting scenario. Tricky to know what value would have to be applied that the shareholders would approve, when the company is growing exponentially. A bit like holding onto a rising balloon.

Not jealous. But learning from them. :)
And enjoying N4P starting to put a few consistent blue days in.

Awww thanks guys. I appreciate your efforts in educating me . You think you know enough and then you find your trousers round your ankles, so to speak.

Cheers

PS: pleased to see I was mistaken. Looking forward to the trading update.

Yeah, Baha normally shows the Ask, but usually across Baha, LSE, and Google, they tie up a little - just thrown by what seemed to be a last minute plunge. Sorry if I set any alarm bells ringing there !

Mgmt not responsible for general market behaviour. They can only report on activity which may substantively alter the market's buy/sell stance.
After all, we all know what happens when a politician publicly says "But there's no reason for panic-buying fuel . . "

Not sure what's happening - my Baha app showed a 6% fall in the final half hour (I checked after markets closed). LSE said 0% but a Prince Monitor. Checked Google and it confirmed a 6.49% drop.

Anyone got a clue why the sudden lurch downwards late this arvo ? Pre-update nerves ? Anyone anticipating anything other than a positive commercial progress ?

Love that, Gecko. It's kind of how I'd describe all investing on AIM.
Tend to agree the floor is very high teens here. News overdue.

Correct me if I'm wrong.

(yawn)

. . . yet a bounce on the path ahead.

I think I know what you're getting at Lochranzalad. But there has to be quite a LOT of judgement. If it were luck then let me have a go - I'm a lucky idiot. The reason CB has a team in place is for their experience which can be applied to interpretation of seismics, etc.
Got to say I am a little frustrated here though. Junior explorers are a (ahem) minefield, but ECR just seems to have had a run of disappointing RNSs through 2021. Looks well placed to deliver the goods but has so far just not actually done it.
A bit like Man Utd (oh good grief - why do I say these things ?). I guess it comes down to this question: has the exploration been unlucky, or is there a lack of competence at play ? I know better investors who believe strongly in ECR, and so I'm happy to assume misfortune. But much more of this, and I might start to doubt.

Oh I love to see a couple of opinion-based posts trying to undermine belief. I've seen so many "dog still falling" type posts over the last year. Sometimes they're right (I did lose on RMS which was a silly rush of blood to the "buy-button", thankfully minimised the loss to 20%), but often they're wrong (check Valirx as a prime example - six months sitting in the doldrums at 19-21p, while several voices used the same phrase of "this is a dog of a share"). It briefly touched 17p and has since tripled in a month.
It's all a matter of timescale; are we expecting an immediate and everlasting rocket ? No. Are we expecting significant progress next year ? Something like that. So today's price is just a step on the journey.
It's weird seeing comments about this share being a dog, (or similar deramping nonsense) when it's right at the point of inflection. Are they trying to convince people to sell so they themselves can accumulate at a lower price, whilst all the time knowing the fundamentals are in place ?

To reiterate RNSs over the last 12-18 months to provide evidence of the fundamentals:
Technical Product perspective:
AEGIS H2H study published May 2020 confirms efficacy is equivalent of I.V. This study is reiterated with further study published in August 2021.
June 2020 - Ferracru/Accrufer confirmed as suitable treatment for patients with IBD, or with Hypertension
July 2020 - publication in Nephrology Dialysis Transplantation confirming Ferracru/Accrufer efficacy in those suffering with kidney disease
March 2021 - the BMJ publishes positive results from real-world field trial of Ferracru/Accrufer

In other words, it works. And there's a market for it.

From a business perspective:
Federal approval granted in: USA, Europe, Australia, China, NZ, South Korea.
Oct 2020 - TEVA Pharma withdraws its legal claim to copyright infringement
Licence Agreement struck in South Korea (Aug 21)
Licence Agreement struck in China
European Sales in 2020 up by 70% over 2019 (albeit from a very low base !) followed by 50% increase in sales volumes in 2021 over 2020.
A sudden drop in revenues in H1 2021 to only £500K - not really addressed in half-year report, but inference is that Norgine is not doing the business. That can be addressed either with Norgine or with an alternative route to market.
Brian Groch leading on US market penetration, while Tim Watts replaced by Greg Madison, and a new CFO in place since the Spring 2021.

To look at the 1 or 2 year chart on its own, you'd be fooled into thinking it's a dog. But as soon as you look at the detail you see it's either on the launchpad, or trundling its way towards the launchpad (I believe it's the latter, tbh).
Now is exactly the time to accumulate, which is why you get those "this company sucks" type of posts. They're smart people, really. A-holes. But smart a-holes.

Long post - sorry. Just my way of explaining why I believe this is the time to buy and/or hold, even if there's yet a bou